Retour aux projets

14666.1 PFLS-LS

Immunotherapy against Alzheimer's disease: encapsulated cell devices as a platform for passive immunization

Résumé

Immunotherapy against Alzheimer's disease: encapsulated cell devices as a platform for passive immunization

Textes supplémentaires

Abstract

The project will develop an innovative bioactive implant for passive immunization against toxic protein entities involved in|neurodegenerative brain disorders. In particular, we will focus on immunotherapy against the amyloid ! peptide, which|abnormally accumulates in the brain of Alzheimer¿s disease patients and is considered a primary actor in the disease process.|Early intervention is key to the success of neuroprotective treatments for Alzheimer¿s disease. Therefore, our aim is to make|preventive immunization against the amyloid ! peptide affordable to patients using self-sustaining and retrievable cellular|implants.

Participants

Bernd Bohrmann

Wirtschaftspartner

bernd.bohrmann@roche.com

F. Hoffmann-La Roche AG CHE-105.815.381 Bernd Bohrmann Grenzacherstrasse 124 4070 Basel BS CH

Bernard Schneider

Kontaktperson

bernard.schneider@epfl.ch

EPFL IC IIF LABOS Bernard Schneider Station 9, Bâtiment AI 2241 1015 Lausanne VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2012-11-30
Date de fin
2015-05-31
Coûts totaux approuvés
CHF 460727.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%